With continuing pressure from the IAEA to abolish the use of radioactive sources, the cobalt-free ZAP-X at the Swiss Neuro Radiosurgery Center (SNRC) has ensured the long-term viability of their SRS investment. SNRC initiated first patient treatments on June 16, 2021.
Considered among the most accomplished radiosurgery providers in the world, neurosurgeon Alex Muacevic and the European CyberKnife Center in Munich recently commenced installation of its ZAP-X Gyroscopic Radiosurgery platform.
With regional recurrence rates post-SRS ranging from 67% to 76%, minimal mean whole brain dose is a critical enabler for future potential radiosurgical re-treatment. A recent multiple mets ZAP-X study demonstrated exceptionally low mean whole brain dose and 100% target coverage using 0 mm PTV margins - not to mention, remarkably rapid planning and delivery times.
UPMC Hillman Cancer Center will be the first cancer center in the eastern United States, and one of just a handful in the country, to offer the most advanced radiotherapy system for treating patients.
The RefleXion™X1 is the world’s first biology-guided radiotherapy (BgRT) machine that’s expected to improve treatment and expand options for patients with metastatic disease, where few treatments are currently available.
Elekta received FDA clearance for a new linear accelerator called Elekta Harmony. Elekta Harmony is built for productivity, versatility and precision and features the new FastTrack workflow experience.